Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown promising prospects in locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma (GC/GEJC) immunotherapy, but their efficacy in neoadjuvant settings remains unclear. This study aimed to assess the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zhen, Cui, Hao, Wang, Shuyuan, Liang, Wenquan, Cao, Bo, Song, Liqiang, Liu, Guibin, Huang, Jun, Chen, Lin, Wei, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909552/
https://www.ncbi.nlm.nih.gov/pubmed/36776290
http://dx.doi.org/10.3389/fonc.2023.1103320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909552/
https://www.ncbi.nlm.nih.gov/pubmed/36776290
http://dx.doi.org/10.3389/fonc.2023.1103320

Ejemplares similares